Clinical Trial Update: Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating Orca-T in allogeneic stem cell transplantation for hematologic malignancies; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndrome
• Therapy-related Myelodysplastic Syndrome
• Undifferentiated Leukemia

Drugs mentioned

• Orca-T

Snippet

Sponsor: Orca Biosystems, Inc. | Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-26